Geode Capital Management’s Profound Medical PROF Stock Holding History

Geode Capital Management’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$162K	Buy	24,431 +3,085	+14%	+$20.7K	﹤0.01%	3982
2026 Q1	$138K	Buy	21,346 +7,297	+52%	+$50.4K	﹤0.01%	4039
2025 Q4	$111K	Hold	14,049	–	–	﹤0.01%	4072
2025 Q3	$70K	Hold	14,049	–	–	﹤0.01%	4216
2025 Q2	$82.9K	Hold	14,049	–	–	﹤0.01%	4111
2025 Q1	$81.8K	Hold	14,049	–	–	﹤0.01%	4085
2024 Q4	$106K	Hold	14,049	–	–	﹤0.01%	4085
2024 Q3	$112K	Hold	14,049	–	–	﹤0.01%	4075
2024 Q2	$119K	Hold	14,049	–	–	﹤0.01%	4086
2024 Q1	$120K	Buy	14,049 +2,410	+21%	+$20.1K	﹤0.01%	4101
2023 Q4	$98.8K	Hold	11,639	–	–	﹤0.01%	4188
2023 Q3	$119K	Hold	11,639	–	–	﹤0.01%	4188
2023 Q2	$151K	Buy	11,639 +769	+7%	+$9.54K	﹤0.01%	4168
2023 Q1	$101K	Hold	10,870	–	–	﹤0.01%	4332
2022 Q4	$118K	Hold	10,870	–	–	﹤0.01%	4338
2022 Q3	$43K	Hold	10,870	–	–	﹤0.01%	4797
2022 Q2	$79K	Hold	10,870	–	–	﹤0.01%	4661
2022 Q1	$97K	Hold	10,870	–	–	﹤0.01%	4671
2021 Q4	$122K	Hold	10,870	–	–	﹤0.01%	4661
2021 Q3	$159K	Hold	10,870	–	–	﹤0.01%	4528
2021 Q2	$177K	Buy	+10,870	New	+$202K	﹤0.01%	4383

Other funds holding PROF

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ZCP

Z3 Capital Partners Richmond, Virginia $476M AUM

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Geode Capital Management's PROF Position: Q2 2026 in Review

Geode Capital Management increased its Profound Medical (PROF) stake by 14% in Q2 2026, buying an estimated $20.7K and bringing the position to 24,431 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #3982.

Geode Capital Management first reported a position in PROF in Q2 2021 and has held it in 21 quarters since. The position peaked at $177K in Q2 2021. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

Geode Capital Management held 24,431 shares of Profound Medical worth $162K as of Q2 2026.
Geode Capital Management bought 3,085 Profound Medical shares in Q2 2026, an estimated $20.7K.
Profound Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3982 holding.
Geode Capital Management first reported a position in Profound Medical in Q2 2021 and has held it in 21 quarters since.
Geode Capital Management's Profound Medical position peaked at $177K in Q2 2021.
56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.